diazepam has been researched along with Schizophrenia in 145 studies
Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lorazepam-diazepam protocol can rapidly relieve retarded catatonia in schizophrenia." | 9.17 | Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. ( Huang, TL; Lin, CC, 2013) |
| "Efficacy data support the use of diazepam in treating prodromal and early warning signs of symptom exacerbation in schizophrenia." | 9.09 | Diazepam treatment of early signs of exacerbation in schizophrenia. ( Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B, 1999) |
| "The purpose of the present paper was to remind physicians that hypothermia is a possible side-effect of combining zotepine, valproate,and benzodiazepine." | 7.72 | Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy. ( Chen, KC; Chen, PS; Yang, MJ; Yang, YK; Yeh, TL, 2003) |
| "Previously, it was shown that subchronic application of the NMDA receptor antagonist ketamine (Ket) induces schizophrenia-related alterations, e." | 7.72 | Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. ( Becker, A; Grecksch, G, 2004) |
| "Trials of novel compounds for the treatment of schizophrenia are typically tested in patients following brief withdrawal of ongoing medication despite known long-term changes in the dopamine (DA) system following chronic antipsychotic drug therapy." | 5.40 | Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. ( Cook, JM; Gill, KM; Grace, AA; Poe, MM, 2014) |
| "Schizophrenia is believed to arise from an interaction of genetic predisposition and adverse environmental factors, with stress being a primary variable." | 5.39 | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. ( Du, Y; Grace, AA, 2013) |
| "We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone." | 5.34 | Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. ( Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M, 2007) |
| "The lorazepam-diazepam protocol can rapidly relieve retarded catatonia in schizophrenia." | 5.17 | Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. ( Huang, TL; Lin, CC, 2013) |
| "Efficacy data support the use of diazepam in treating prodromal and early warning signs of symptom exacerbation in schizophrenia." | 5.09 | Diazepam treatment of early signs of exacerbation in schizophrenia. ( Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B, 1999) |
| "We have shown previously that aberrant hippocampal (HPC) output underlies the dopamine (DA) dysfunction observed in the methylazoxymethanol acetate (MAM) developmental model of schizophrenia in the rodent." | 3.77 | A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia. ( Aras, S; Cook, JM; Gill, KM; Grace, AA; Lodge, DJ, 2011) |
| "The purpose of the present paper was to remind physicians that hypothermia is a possible side-effect of combining zotepine, valproate,and benzodiazepine." | 3.72 | Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy. ( Chen, KC; Chen, PS; Yang, MJ; Yang, YK; Yeh, TL, 2003) |
| "Previously, it was shown that subchronic application of the NMDA receptor antagonist ketamine (Ket) induces schizophrenia-related alterations, e." | 3.72 | Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. ( Becker, A; Grecksch, G, 2004) |
| " In 37 patients with anxiety depression the DST was combined with the diazepam test." | 3.67 | [Use of the dexamethasone test in the differential diagnosis of depressive states]. ( Gordon, OI; Nuller, IuL; Ostroumova, MN, 1986) |
| "Three patients, aged 23-33 years, with the diagnosis of schizophrenia, developed symptoms of tardive dyskinesia while receiving neuroleptic treatment, mostly with haloperidol." | 3.65 | Diazepam in the treatment of tardive dyskinesia. Preliminary observations. ( Singh, MM, 1976) |
| "Diazepam was given intravenously to the patients at a rate of 5 mg per 30 seconds." | 2.70 | Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study. ( Ashby, CR; Hirose, S, 2002) |
| "Diazepam treatment led to a return of the patient's usual condition in seven of 11 episodes." | 2.66 | Diazepam treatment of early symptoms of schizophrenic relapse. ( Buchanan, RW; Carpenter, WT; Jauch, D; Kirkpatrick, B; Waltrip, RW, 1989) |
| " By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
| "Trials of novel compounds for the treatment of schizophrenia are typically tested in patients following brief withdrawal of ongoing medication despite known long-term changes in the dopamine (DA) system following chronic antipsychotic drug therapy." | 1.40 | Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia. ( Cook, JM; Gill, KM; Grace, AA; Poe, MM, 2014) |
| "Schizophrenia is believed to arise from an interaction of genetic predisposition and adverse environmental factors, with stress being a primary variable." | 1.39 | Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. ( Du, Y; Grace, AA, 2013) |
| " There were no other adverse events." | 1.36 | The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT. ( Andrade, C; Bhakta, S; Bhirud, M; Fernandes, P; Mahadeshwar, S; Shah, N, 2010) |
| "We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone." | 1.34 | Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. ( Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M, 2007) |
| " It highlights three features: first, MHN can safely prescribe psychiatric medication in combination with concordance therapy." | 1.33 | Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant. ( Arya, P; Bennett, J; Gray, R; Jones, M; Lucas, B, 2006) |
| "The diazepam dose was adjusted daily to avoid oversedation." | 1.27 | High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients. ( Bloom, D; Nair, NP; Nestoros, JN; Pulman, JR; Schwartz, G, 1983) |
| "Diazepam treatment with doses up to 250 mg/day caused no significant rise in SPL, while the treatment with doses of higher than 250 mg/day resulted in a mild but still significant increase in SPL." | 1.27 | High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients. ( Ben David, M; Tyano, S; Weizman, A; Wijsenbeek, H, 1984) |
| " We also report results on using this assay in a pharmacokinetic study of high doses of diazepam used to treat chronic schizophrenic patients." | 1.27 | Liquid-chromatographic assay of diazepam and its major metabolites in serum, and application to pharmacokinetic study of high doses of diazepam in schizophrenics. ( Moroji, T; Motomura, H; Noguchi, T; Sekiguchi, R; Tada, K, 1985) |
| "Diazepam was also effective in reducing the cardiac response." | 1.26 | Changes in heart rate during administration of local anesthetics in neuropsychiatric patients. ( Nakajima, T; Yakata, H; Yokobayashi, T, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 106 (73.10) | 18.7374 |
| 1990's | 15 (10.34) | 18.2507 |
| 2000's | 12 (8.28) | 29.6817 |
| 2010's | 12 (8.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, T | 1 |
| Wang, W | 1 |
| Williams, J | 1 |
| Ma, K | 1 |
| Cao, Q | 1 |
| Yan, Z | 1 |
| Afonso, P | 1 |
| Saraiva, S | 1 |
| Gameiro, Z | 1 |
| Du, Y | 3 |
| Grace, AA | 5 |
| Lin, CC | 1 |
| Huang, TL | 1 |
| Gill, KM | 2 |
| Cook, JM | 2 |
| Poe, MM | 1 |
| Mukhopadhaya, K | 1 |
| Krishnaiah, R | 1 |
| Taye, T | 1 |
| Nigam, A | 1 |
| Bailey, AJ | 1 |
| Sivakumaran, T | 1 |
| Fineberg, NA | 1 |
| Shah, N | 1 |
| Mahadeshwar, S | 1 |
| Bhakta, S | 1 |
| Bhirud, M | 1 |
| Fernandes, P | 1 |
| Andrade, C | 1 |
| Morera-Fumero, AL | 1 |
| Abreu-Gonzalez, P | 1 |
| Feifel, D | 1 |
| Shilling, PD | 1 |
| Melendez, G | 1 |
| Loga-Zec, S | 1 |
| Loga, S | 1 |
| Lodge, DJ | 1 |
| Aras, S | 1 |
| Bellgrove, MA | 1 |
| Vance, A | 1 |
| Bradshaw, JL | 1 |
| Chen, KC | 1 |
| Yang, YK | 1 |
| Chen, PS | 1 |
| Yeh, TL | 1 |
| Yang, MJ | 1 |
| FELDMAN, PE | 1 |
| POELDINGER, W | 1 |
| GROSS, H | 1 |
| KALTENBAECK, E | 1 |
| HOLLISTER, LE | 3 |
| BENNETT, JL | 1 |
| KIMBELL, I | 2 |
| SAVAGE, C | 1 |
| OVERALL, JE | 4 |
| KALINA, RK | 1 |
| MACULANS, GA | 1 |
| LEHMANN, HE | 2 |
| BAN, TA | 2 |
| INVERNIZZI, G | 1 |
| DEBERDT, R | 2 |
| HARDER, A | 1 |
| GOLD, RL | 1 |
| DRIBBEN, IS | 1 |
| DEAN, SR | 1 |
| GALAMBOS, M | 1 |
| Sielk, M | 1 |
| Bowers, L | 1 |
| Callaghan, P | 1 |
| Clark, N | 1 |
| Evers, C | 1 |
| Becker, A | 1 |
| Grecksch, G | 1 |
| Yee, BK | 1 |
| Keist, R | 1 |
| von Boehmer, L | 1 |
| Studer, R | 1 |
| Benke, D | 1 |
| Hagenbuch, N | 1 |
| Dong, Y | 1 |
| Malenka, RC | 1 |
| Fritschy, JM | 1 |
| Bluethmann, H | 1 |
| Feldon, J | 1 |
| Möhler, H | 1 |
| Rudolph, U | 1 |
| Jones, M | 1 |
| Bennett, J | 1 |
| Gray, R | 1 |
| Arya, P | 1 |
| Lucas, B | 1 |
| Hashimoto, T | 1 |
| Lewis, DA | 1 |
| Ozen, ME | 1 |
| Yumru, M | 1 |
| Savas, HA | 1 |
| Cansel, N | 1 |
| Herken, H | 1 |
| McLeod, MC | 1 |
| Sundram, S | 1 |
| Dean, B | 1 |
| Belmaker, RH | 3 |
| Lerner, Y | 2 |
| Ebstein, RP | 1 |
| Kim, JS | 1 |
| Kornhuber, HH | 1 |
| Schmid-Burgk, W | 1 |
| Holzmüller, B | 1 |
| Singh, MM | 2 |
| Becker, RE | 1 |
| Pitman, RK | 1 |
| Nasrallah, HA | 1 |
| Lal, H | 1 |
| Dufresne, RL | 1 |
| Weber, SS | 1 |
| McCalley-Whitters, M | 1 |
| Nuller, JL | 1 |
| Tochilov, VA | 1 |
| Shirokov, VD | 1 |
| Nishikawa, T | 1 |
| Tsuda, A | 1 |
| Tanaka, M | 1 |
| Koga, I | 1 |
| Uchida, Y | 1 |
| Rhoades, HM | 1 |
| Nestoros, JN | 2 |
| Nair, NP | 2 |
| Pulman, JR | 1 |
| Schwartz, G | 1 |
| Bloom, D | 1 |
| Gramsch, C | 1 |
| Emrich, HM | 3 |
| John, S | 1 |
| Haas, S | 3 |
| Beckmann, H | 3 |
| Zaudig, M | 1 |
| von Zerssen, D | 2 |
| Rommelspacher, H | 1 |
| Barbey, M | 1 |
| Strauss, S | 1 |
| Greiner, B | 1 |
| Fähndrich, E | 1 |
| Altmann, H | 1 |
| Dose, M | 1 |
| Weizman, A | 2 |
| Tyano, S | 2 |
| Wijsenbeek, H | 2 |
| Ben David, M | 1 |
| Kaminer, Y | 1 |
| Munitz, H | 2 |
| Jimerson, DC | 1 |
| van Kammen, DP | 1 |
| Post, RM | 1 |
| Docherty, JP | 1 |
| Bunney, WE | 1 |
| Boleloutskiĭ, Z | 1 |
| Arató, M | 1 |
| Bagdy, G | 1 |
| Zuardi, AW | 1 |
| Morais, SL | 1 |
| Guimarães, FS | 1 |
| Mechoulam, R | 1 |
| Benazzi, F | 1 |
| Mazzoli, M | 1 |
| Rossi, E | 1 |
| Jaspert, A | 1 |
| Ebert, D | 1 |
| Rosebush, PI | 1 |
| Mazurek, MF | 1 |
| Remington, G | 2 |
| Fornazzari, L | 1 |
| Sethna, R | 1 |
| Vieweg, WV | 1 |
| Bustillo, J | 1 |
| Buchanan, RW | 3 |
| Carpenter, WT | 3 |
| Schröder, J | 2 |
| Bubeck, B | 1 |
| Demisch, S | 1 |
| Sauer, H | 1 |
| Miyaoka, H | 1 |
| Shishikura, K | 1 |
| Otsubo, T | 1 |
| Muramatsu, D | 1 |
| Kamijima, K | 1 |
| Kirkpatrick, B | 2 |
| Breier, AF | 1 |
| Hoffmann-Richter, U | 1 |
| Hatta, K | 1 |
| Takahashi, T | 1 |
| Nakamura, H | 1 |
| Yamashiro, H | 1 |
| Endo, H | 1 |
| Kito, K | 1 |
| Fujii, S | 1 |
| Matsuzaki, I | 1 |
| Masui, K | 1 |
| Yonezawa, Y | 1 |
| Chong, SA | 1 |
| Tan, CH | 1 |
| Hirose, S | 1 |
| Ashby, CR | 1 |
| Yakata, H | 1 |
| Yokobayashi, T | 1 |
| Nakajima, T | 1 |
| Trabucchi, M | 1 |
| Ba, G | 1 |
| Nistri, A | 1 |
| Bjerkenstedt, L | 2 |
| Gullberg, B | 1 |
| Härnryd, C | 1 |
| Sedvall, G | 1 |
| Holzman, PS | 1 |
| Baumann, P | 1 |
| Azcarate, CL | 1 |
| Weizman, R | 1 |
| David, MB | 1 |
| Lwow, E | 1 |
| Levitin, A | 1 |
| Saito, M | 1 |
| Ruskin, P | 1 |
| Averbukh, I | 1 |
| Dasberg, H | 1 |
| Kryzhanovskiĭ, GN | 1 |
| Aliev, MN | 1 |
| Adebimpe, VR | 1 |
| McLeod, MN | 1 |
| Fisher, P | 1 |
| Abrams, RS | 1 |
| Bellak, L | 2 |
| Itil, TM | 1 |
| Herrmann, WM | 1 |
| Akpinar, S | 1 |
| Velamoor, VR | 1 |
| Sczesni, B | 1 |
| Becker, H | 1 |
| Bittkau, S | 1 |
| von Baumgarten, F | 1 |
| Truong, DD | 1 |
| Przuntek, H | 1 |
| Bacher, NM | 1 |
| Field, PB | 1 |
| Elkashef, A | 1 |
| Waltrip, RW | 1 |
| Jauch, D | 1 |
| Suranyi-Cadotte, BE | 1 |
| Lal, S | 1 |
| Gauthier, S | 1 |
| Smulevich, AB | 2 |
| Vorob'ev, VIu | 2 |
| Dubnitskaia, EB | 1 |
| Maksimov, VI | 1 |
| Novikov, VN | 1 |
| Tarasova, TP | 1 |
| Abrosimov, AI | 1 |
| Hermesh, H | 1 |
| Molcho, A | 1 |
| Schnetzler, JP | 1 |
| Préaubert, G | 1 |
| Schnetzler, F | 1 |
| Csernansky, JG | 1 |
| Riney, SJ | 1 |
| Lombrozo, L | 1 |
| Nuller, IuL | 1 |
| Ostroumova, MN | 1 |
| Gordon, OI | 1 |
| Roberts, K | 1 |
| Vass, N | 1 |
| Finkel, JA | 1 |
| Tada, K | 1 |
| Moroji, T | 1 |
| Sekiguchi, R | 1 |
| Motomura, H | 1 |
| Noguchi, T | 1 |
| Keegan, DL | 1 |
| Rajput, AH | 1 |
| Dencker, SJ | 1 |
| Frankenberg, K | 1 |
| Malm, U | 1 |
| Zell, B | 1 |
| Máthé, V | 1 |
| Kassay, G | 1 |
| Tüske, M | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
| Udabe, RU | 1 |
| Newbold, HL | 1 |
| Mosher, LR | 1 |
| Aleksandrovskiĭ, IuA | 3 |
| Bragina, NN | 1 |
| Fleĭs, EP | 1 |
| Seeman, MV | 1 |
| Denber, HC | 1 |
| Goldner, F | 1 |
| Prokudin, VN | 3 |
| Chassan, JB | 1 |
| Gediman, HK | 1 |
| Hurvich, M | 1 |
| Raskin, A | 2 |
| Schulterbrandt, JG | 1 |
| Reatig, N | 1 |
| Crook, TH | 1 |
| Odle, D | 1 |
| Ayd, FJ | 1 |
| Rickels, K | 1 |
| Weise, CC | 1 |
| Clark, EL | 1 |
| Jenkins, BW | 1 |
| Rose, CK | 1 |
| Rosenfeld, H | 1 |
| Gordon, PE | 1 |
| Zsadányi, O | 1 |
| Molnár, C | 1 |
| Karno, M | 1 |
| Gram, LF | 1 |
| Overo, K | 1 |
| Kirk, L | 1 |
| Gundlach, R | 1 |
| Engelhardt, DM | 1 |
| Hankoff, L | 1 |
| Paley, H | 1 |
| Rudorfer, L | 1 |
| Bird, E | 1 |
| Michaux, L | 1 |
| Gallot, HM | 1 |
| Schneider, JJ | 1 |
| Sakurai, T | 1 |
| Nishizono, M | 1 |
| Noiri, T | 1 |
| Kammerer, M | 1 |
| Wartel, R | 1 |
| Gurfein, L | 1 |
| Weil, J | 1 |
| Wysoki, V | 1 |
| Gelb, F | 1 |
| Angst, J | 1 |
| Takeshima, T | 1 |
| Yamaguchi, N | 1 |
| Okabe, M | 1 |
| Ando, J | 1 |
| Takeuchi, O | 1 |
| Soyka, D | 1 |
| Fracchia, J | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Korczyn, AD | 1 |
| Goldberg, GJ | 1 |
| Glatzel, J | 1 |
| Borelli, N | 1 |
| Marjerrison, G | 1 |
| Naviau, J | 1 |
| Wolpowitz, B | 1 |
| Roux, JT | 1 |
| Dally, P | 1 |
| Perlson, P | 1 |
| Tobin, JM | 1 |
| Vikhliaev, IuI | 1 |
| Klygul', TA | 1 |
| Adronati, SA | 1 |
| Langner, E | 1 |
| Spiegelberg, U | 1 |
| Petrilowitsch, N | 1 |
| Betz, B | 1 |
| Irvine, BM | 1 |
| Baliarda, A | 1 |
| Shelton, J | 1 |
| Hodel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| MK-0777 for the Treatment of Cognitive Impairments in Patients With Schizophrenia[NCT00505076] | Phase 2 | 63 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome measure is the composite score on the Matrics Consensus Cognitive Battery (MCCB). The MCCB composite score is a standardized mean of the seven domain scores. T-scores are standardized to normative data, and have an estimated mean of 50 and SD of 10 in the general healthy population. Data reduction for analysis of neurocognitive testing used the following steps: i) individual neurocognitive test scores at baseline and follow-up were converted to t-scores; ii) t-scores within the pre-specified cognitive domains measured by more than one test were averaged to obtain a domain-specific t-score; and iii) domain-specific t-scores were averaged to create the MCCB composite score. (NCT00505076)
Timeframe: 4 weeks
| Intervention | composite score (Mean) |
|---|---|
| MK-077 8 mg BID | 27.9 |
| MK-0777 3 mg BID | 31.3 |
| Placebo BID | 32.5 |
The Schizophrenia Cognition Rating Scale (SCoRS) assessed functional capacity. The SCoRS Interviewer Global Rating of function has a range 1 to 10. Higher ratings indicate greater impairment. (NCT00505076)
Timeframe: 4 Weeks (Baseline to End of Treatment)
| Intervention | SCoRS Score (Mean) | |
|---|---|---|
| Baseline | End of Treatment | |
| MK-077 8 mg BID | 4.1 | 4.0 |
| MK-0777 3 mg BID | 4.8 | 4.6 |
| Placebo BID | 3.8 | 3.6 |
The UCSD Performance-Based Skills Assessment assessed functional capacity. The UPSA Summary Score has a range from 0 to 120. A higher score indicates less impairment. (NCT00505076)
Timeframe: Baseline and end of treatment, a total of four weeks.
| Intervention | UPSA Summary Score (Mean) | |
|---|---|---|
| Baseline | End of Treatment | |
| MK-077 8 mg BID | 91.7 | 90.4 |
| MK-0777 3 mg BID | 85.0 | 86.3 |
| Placebo BID | 95.0 | 96.5 |
10 reviews available for diazepam and Schizophrenia
| Article | Year |
|---|---|
[Problems with the treatment of schizophrenics in the doctor's office].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Drug Therapy, Combination | 2003 |
Prodromal symptoms vs. early warning signs and clinical action in schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Humans; Psychiatric Status Rating Scales; Recur | 1995 |
[ECT: The apple of discord in modern psychiatry (author's transl)].
Topics: Aggression; Anxiety; Atropine; Biogenic Amines; Confusion; Cyclic AMP; Depression; Diazepam; Electro | 1979 |
Minor tranquilizers in the treatment of aggression.
Topics: Aggression; Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Depression; Diazepam; Epilepsy; | 1975 |
[A valproic acid-diazepam combination as an alternative to neuroleptic treatment].
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Diazepam; Drug Combinations; Female; Humans; Male; | 1988 |
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depressio | 1973 |
[Features of the clinical effect of benzodiazepine derivatives (according to the findings of comparative studies). Review of the literature].
Topics: Adjustment Disorders; Aggression; Animals; Antisocial Personality Disorder; Barbiturates; Benzazepin | 1973 |
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Prepar | 1974 |
[Recent developments in psychopharmacology].
Topics: Antidepressive Agents; Barbiturates; Bipolar Disorder; Chlormethiazole; Depression; Diazepam; Electr | 1968 |
30 trials available for diazepam and Schizophrenia
| Article | Year |
|---|---|
Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.
Topics: Anti-Anxiety Agents; Catatonia; Clinical Protocols; Diazepam; Drug Therapy, Combination; Humans; Lor | 2013 |
Prophylactic effect of neuroleptics in symptom-free schizophrenics.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Diazepam; Female; Haloperidol; Humans; Imipramine; Male | 1982 |
The significance of treatment effects across several independent studies.
Topics: Antipsychotic Agents; Anxiety Disorders; Arousal; Clinical Trials as Topic; Diazepam; Dihydroergotox | 1981 |
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as | 1983 |
Diazepam in schizophrenia: a preliminary double-blind trial.
Topics: Adult; Clinical Trials as Topic; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Fe | 1982 |
Analgesic and euphoric effects of high dose diazepam in schizophrenia.
Topics: Adult; Analgesia; Diazepam; Endorphins; Euphoria; Female; Humans; Male; Middle Aged; Naloxone; Pain; | 1982 |
Placebo response in refractory tardive akathisia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Diazepam; Double-Blind Method; Humans; Male; Middle A | 1993 |
Prodromal symptoms vs. early warning signs and clinical action in schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Humans; Psychiatric Status Rating Scales; Recur | 1995 |
Diazepam treatment of early signs of exacerbation in schizophrenia.
Topics: Acute Disease; Adult; Age of Onset; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Drug Admini | 1999 |
The predictive value of benzodiazepine tolerance in persistently aggressive schizophrenia.
Topics: Adolescent; Adult; Aggression; Biomarkers; Diazepam; Drug Tolerance; Humans; Hypnotics and Sedatives | 1999 |
Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Di | 2002 |
Acute high-dose parenteral haloperidol treatment of psychosis.
Topics: Acute Disease; Adult; Bipolar Disorder; Blood Pressure; Clinical Trials as Topic; Diazepam; Dose-Res | 1979 |
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
Melperone in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Butyrophenones; Diazepam; Double-Blind Method; Drug Therapy, Combination; Homo | 1989 |
Diazepam treatment of early symptoms of schizophrenic relapse.
Topics: Administration, Oral; Clinical Trials as Topic; Diazepam; Female; Humans; Male; Recurrence; Schizoph | 1989 |
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.
Topics: Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; | 1988 |
A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as | 1973 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depressio | 1973 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
Ego function assessment of analytic psychotherapy combined with drug therapy.
Topics: Adult; Clinical Trials as Topic; Defense Mechanisms; Diazepam; Ego; Evaluation Studies as Topic; Fem | 1973 |
Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
Topics: Adolescent; Adult; Anxiety; Bipolar Disorder; Clinical Trials as Topic; Depression; Diazepam; Drug E | 1974 |
Thiothixene and thioridazine in anxiety.
Topics: Antisocial Personality Disorder; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Diazepam; Fema | 1974 |
A double-blind outpatient study of diazepam (Valium) and placebo.
Topics: Adolescent; Adult; Ambulatory Care; Anxiety; Clinical Trials as Topic; Depressive Disorder, Major; D | 1966 |
[Hypnotic effect of Nitrazepam, a new benzodiazepine derivative].
Topics: Bipolar Disorder; Clinical Trials as Topic; Diazepam; Humans; Hypnotics and Sedatives; Neurotic Diso | 1967 |
[Clinical experimentation with desipramine with statistical control].
Topics: Adult; Aged; Anorexia Nervosa; Barbiturates; Bipolar Disorder; Chlordiazepoxide; Chlorpromazine; Cli | 1968 |
[Animal and clinical experiments on the hypnotic effects of nitrazepam].
Topics: Adult; Aged; Animals; Cats; Cerebral Cortex; Clinical Trials as Topic; Diazepam; Electric Stimulatio | 1968 |
[The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus].
Topics: Amitriptyline; Apomorphine; Aporphines; Barbiturates; Chlordiazepoxide; Chlorpromazine; Clinical Tri | 1968 |
Combination medications in psychiatric treatment: patterns in a group of elderly hospital patients.
Topics: Age Factors; Aged; Amitriptyline; Antidepressive Agents; Antihypertensive Agents; Antisocial Persona | 1971 |
Triavil and Etrafon.
Topics: Amitriptyline; Chlordiazepoxide; Clinical Trials as Topic; Depression; Diazepam; Female; Humans; Mep | 1966 |
Diazepam in long-term chronic schizophrenia.
Topics: Clinical Trials as Topic; Diazepam; Female; Humans; Middle Aged; Placebos; Schizophrenia | 1966 |
107 other studies available for diazepam and Schizophrenia
| Article | Year |
|---|---|
Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission.
Topics: Animals; Behavior, Animal; Cognitive Dysfunction; Diazepam; Exploratory Behavior; Female; GABA Modul | 2019 |
Schizophrenia presenting with Koro-like symptoms.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Brain; Diazepam; Electroencephalo | 2013 |
Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.
Topics: Amphetamine; Animals; Anxiety; Central Nervous System Sensitization; Diazepam; Dopaminergic Neurons; | 2013 |
Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
Topics: Allosteric Regulation; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disea | 2014 |
Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
Topics: Action Potentials; Administration, Oral; Amygdala; Animals; Animals, Newborn; Anti-Anxiety Agents; A | 2016 |
Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Diazepam; Disease Models, Animal; Down-Regulation; | 2016 |
Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern.
Topics: Adult; Antipsychotic Agents; Clozapine; Cohort Studies; Cross-Sectional Studies; Diazepam; Dose-Resp | 2009 |
The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT.
Topics: Adolescent; Adult; Benzodiazepines; Child; Depressive Disorder; Diazepam; Electroconvulsive Therapy; | 2010 |
Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression.
Topics: Acetamides; Adult; Anti-Anxiety Agents; Depression; Diazepam; Humans; Hypnotics and Sedatives; Male; | 2010 |
Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Diazepam; Disease Models, Animal; Female; Imipramine; | 2011 |
Polypharmacy in the treatment of schizophrenic patients in three University Centers in the Federation of Bosnia and Herzegovina (F/BH).
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antiparkinson Agents; Antipsycho | 2011 |
A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
Topics: Allosteric Regulation; Amphetamine; Animals; Benzodiazepines; Diazepam; Disease Models, Animal; Dopa | 2011 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female | 2003 |
Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Diazepam; Diben | 2003 |
An analysis of the efficacy of diazepam.
Topics: Chlordiazepoxide; Depression; Depressive Disorder; Diazepam; Schizophrenia; Tranquilizing Agents | 1962 |
[CLINICAL EXPERIENCES WITH THE LIBRIUM ANALOGUE RO 5-2807 (VALIUM) IN PSYCHOTIC STATES].
Topics: Bipolar Disorder; Chlordiazepoxide; Diazepam; Humans; Intellectual Disability; Mental Disorders; Par | 1963 |
[THE ADVANCES OF MODERN PHARMACOTHERAPY OF THE ENDOGENOUS PSYCHOSES AND ITS SIGNIFICANCE FOR INSTITUTIONAL PSYCHIATRY].
Topics: Chlordiazepoxide; Chlorprothixene; Diazepam; Humans; Phenothiazines; Psychiatry; Psychotic Disorders | 1963 |
DIAZEPAM IN NEWLY ADMITTED SCHIZOPHRENICS.
Topics: Depression; Diazepam; Paranoid Disorders; Schizophrenia; Toxicology; Tranquilizing Agents | 1963 |
DIAZEPAM: ITS ROLE IN A PRISON SETTING.
Topics: Adolescent; Diazepam; Epilepsy; Geriatrics; Humans; Mental Disorders; Prisons; Psychotic Disorders; | 1964 |
COMPARISON OF DIAZEPAM, CHLORPROTHIXENE AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS.
Topics: Alcoholism; Brain; Brain Damage, Chronic; Chlorpromazine; Chlorprothixene; Diazepam; Schizophrenia; | 1964 |
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT. II.
Topics: Antidepressive Agents; Books; Dextroamphetamine; Diazepam; Geriatrics; Humans; Mental Disorders; Met | 1964 |
[OBSERVATIONS ON THE USE OF PHENYLPYRROLIDINOPENTANE AS AN ANTIASTHENIC AGENT IN TREATMENT WITH PSYCHOPHARMACOLOGICAL DRUGS].
Topics: Amitriptyline; Anxiety; Anxiety Disorders; Asthenia; Bipolar Disorder; Chemical and Drug Induced Liv | 1964 |
[CLINICAL TRIAL OF A NEW TRANQUILIZER, A BENZODIAZEPINE SERIES DERIVATIVE: RO 5-2807].
Topics: Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Benzodiazepines; Combat Disorders; De | 1964 |
[CLINICAL EXPERIENCES WITH VALIUM ROCHE, A NEW BENZODIAZEPINE DERIVATIVE].
Topics: Antisocial Personality Disorder; Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Benz | 1964 |
DIAZEPAM THERAPY OF DEPRESSED PATIENTS.
Topics: Bipolar Disorder; Chlordiazepoxide; Depression; Depressive Disorder; Depressive Disorder, Major; Dia | 1964 |
DIAZEPAM AS AN ADJUVANT IN PSYCHOTHERAPY.
Topics: Adolescent; Anxiety; Bipolar Disorder; Depression; Depressive Disorder, Major; Diazepam; Drug Therap | 1964 |
AN INTERESTING OBSERVATION IN THE TREATMENT OF CHRONIC PSYCHIATRIC PATIENTS.
Topics: Biomedical Research; Diazepam; Drug Therapy; Patients; Schizophrenia; Schizophrenia, Childhood | 1964 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administ | 2004 |
Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Behavior | 2004 |
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; Dopamine; Electrophysio | 2005 |
Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant.
Topics: Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Diazepam; Drug | 2006 |
BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia.
Topics: Brain-Derived Neurotrophic Factor; Cohort Studies; Diazepam; Female; gamma-Aminobutyric Acid; Gene E | 2006 |
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination | 2007 |
Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Binding Sites; Brain; Diazepam; Dis | 2008 |
Rapid neuroleptization reconsidered.
Topics: Acute Disease; Antipsychotic Agents; Diazepam; Humans; Psychotic Disorders; Schizophrenia | 1980 |
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
Topics: Adult; Antipsychotic Agents; Diazepam; Female; Glutamates; Humans; Male; Middle Aged; Schizophrenia | 1980 |
Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
Topics: Adult; Aged; Antipsychotic Agents; Diazepam; Dose-Response Relationship, Drug; Dyskinesia, Drug-Indu | 1982 |
The use of a diazepam test for the study of depressive state structure and for choice of therapy.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Bipolar Disorder; | 1982 |
High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Diazepam; Drug Resistance; Female; Humans; Male; Middl | 1983 |
The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; beta-Endorphin; Diazepam; Dose-Response Relationship, Drug; | 1984 |
Is there a correlation between the concentration of beta-carbolines and their pharmacodynamic effects?
Topics: Alkaloids; Animals; Benzodiazepines; Blood Platelets; Carbolines; Diazepam; Female; Harmine; Humans; | 1982 |
High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.
Topics: Adolescent; Diazepam; Female; Humans; Male; Prolactin; Schizophrenia | 1984 |
Case report: psychomotor status-like episodes under haloperidol treatment.
Topics: Adult; Diazepam; Epilepsy; Haloperidol; Humans; Male; Schizophrenia | 1984 |
High dose diazepam in schizophrenia.
Topics: Adult; Anxiety; Diazepam; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Sle | 1980 |
[Psychopharmacologic approach to studying various problems in slowly progressive schizophrenia].
Topics: Depressive Disorder; Diagnosis, Differential; Diazepam; Dibenzothiepins; Dothiepin; Humans; Methotri | 1982 |
Neuroendocrine study of the mechanism of action of electroconvulsive therapy.
Topics: Adult; Diazepam; Dopamine beta-Hydroxylase; Electroconvulsive Therapy; Female; Humans; Hydrocortison | 1982 |
Antipsychotic effect of cannabidiol.
Topics: Adult; Cannabidiol; Diazepam; Drug Therapy, Combination; Female; Haloperidol; Humans; Psychiatric St | 1995 |
Auditory hallucinations suppressed by etizolam in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Auditory Perception; Diazepam; Drug Therapy, Combination; Female; Hallu | 1993 |
[Benzodiazepine monotherapy in acute schizophrenia].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Male; Schizophrenia; Schizop | 1994 |
Do benzodiazepines modify the incidence of neuroleptic-induced dystonia?
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Diazepam; Dystonia; Humans; Schizophrenia | 1993 |
Behavioral approaches to polydipsia.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Diazepam; Female; Flurazepam; Humans; Male; Rein | 1993 |
Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study.
Topics: Adult; Benzodiazepines; Binding Sites; Chronic Disease; Diazepam; Flumazenil; Frontal Lobe; Growth H | 1997 |
Diazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype?
Topics: Antipsychotic Agents; Catatonia; Diazepam; Female; Humans; Infusions, Intravenous; Middle Aged; Neur | 1997 |
[Decompensated "anorexia" at age 52--diagnosis of schizophrenia 30 years later].
Topics: Adult; Anorexia; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Female; Haloperidol; Humans; M | 1999 |
Risperidone treatment of tardive dyskinesia and dystonia.
Topics: Antipsychotic Agents; Diazepam; Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Co | 1999 |
Changes in heart rate during administration of local anesthetics in neuropsychiatric patients.
Topics: Adult; Anesthesia, Dental; Anesthesia, Local; Anti-Anxiety Agents; Autonomic Nervous System; Diazepa | 1979 |
Letter: Are benzodiazepines antipsychotic agents?
Topics: Diazepam; Humans; Schizophrenia | 1975 |
Letter: Are benzodiazepines antipsychotic agents?
Topics: Diazepam; Drug Evaluation; Humans; Schizophrenia | 1975 |
Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.
Topics: Butyrophenones; Diazepam; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydrox | 1979 |
Smooth-pursuit eye movements in schizophrenia: recent findings.
Topics: Adult; Attention; Chlorpromazine; Depression; Diagnosis, Differential; Diazepam; Electronystagmograp | 1975 |
Editorial: Tranquillizers causing aggression.
Topics: Aggression; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Group Processes; Haplorhini; H | 1975 |
The biphasic effect of gradually increased doses of diazepam on prolactin secretion in acute schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Diazepam; Female; Humans; Male; Prolactin; Schizophrenia | 1979 |
Drug-induced EEG changes studied on two-dimensional rectangular coordinates using principal component analysis.
Topics: Adult; Amitriptyline; Chlorpromazine; Computers; Diazepam; Electroencephalography; Haloperidol; Huma | 1979 |
Benzodiazepines in chronic schizophrenia.
Topics: Adult; Diazepam; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; | 1979 |
[Pathogenesis of stereotyped behavior].
Topics: Animals; Behavior; Caudate Nucleus; Diazepam; Disease Models, Animal; gamma-Aminobutyric Acid; Halop | 1979 |
Complex partial seizures simulating schizophrenia .
Topics: Adult; Chlorpromazine; Diagnosis, Differential; Diagnostic Errors; Diazepam; Electroencephalography; | 1977 |
Pavor nocturnus in a schizophrenic patient: a review and case study.
Topics: Adult; Chlorpromazine; Diazepam; Dreams; Humans; Male; Schizophrenia; Schizophrenic Psychology; Stre | 1978 |
Psychopharmacology for psychiatric and psychiatric-organic diseases.
Topics: Antidepressive Agents, Tricyclic; Anxiety; Depression; Diazepam; Dose-Response Relationship, Drug; D | 1978 |
A possible subgroup of the schizophrenic syndrome and implications for treatment.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Diazepam; Dominance, Cerebral; Dys | 1976 |
Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
Topics: Adult; Chlorpromazine; Diazepam; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Schizo | 1976 |
NMS complicated by diazepam.
Topics: Aged; Coma; Diazepam; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risk Factors; Schiz | 1992 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; D | 1991 |
Possible enhancing effects of diazepam with reserpine in a chronic schizophrenic patient with tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Diazepam; Drug Therapy, Combination; Dyskinesia, Drug- | 1989 |
Parkinsonism induced by high doses of diazepam.
Topics: Adult; Antipsychotic Agents; Diazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Middl | 1985 |
[Intensive psychopharmacologic therapy of slowly-progressive schizophrenia].
Topics: Adult; Antipsychotic Agents; Chlordiazepoxide; Diazepam; Female; Fluphenazine; Humans; Infusions, Pa | 1985 |
[Psychotropic drug therapy using maintenance dosage pumps].
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Diazepam; Dibenzazepines; Female; Humans; Infusi | 1987 |
Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Diazepam; Female; Humans; Male; Propranolol; P | 1988 |
[Use of the dexamethasone test in the differential diagnosis of depressive states].
Topics: 11-Hydroxycorticosteroids; Adolescent; Adult; Aged; Anxiety; Bipolar Disorder; Depression; Depressiv | 1986 |
Schneiderian first-rank symptoms caused by benzodiazepine withdrawal.
Topics: Adult; Benzodiazepines; Diazepam; Female; Hallucinations; Humans; Middle Aged; Schizophrenia; Substa | 1986 |
Diazepam in a patient with chronic schizophrenia complicated by agoraphobia.
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Diazepam; Humans; Male; Phobic Diso | 1987 |
Liquid-chromatographic assay of diazepam and its major metabolites in serum, and application to pharmacokinetic study of high doses of diazepam in schizophrenics.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Diazepam; Female; Humans; Kinetics; Nord | 1985 |
Drug induced dystonia tarda: treatment with L-dopa.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Diazepam; Dihydroxyphenylalanine; Dystonia Mu | 1973 |
[Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Chlorpromazine; Diazepam; Glucose Tolerance Test; Haloperidol; Hum | 1971 |
Niacin and the schizophrenic patient.
Topics: Diazepam; Edema; Gastrointestinal Diseases; Humans; Liver Function Tests; Mental Disorders; Niacinam | 1970 |
[Neurological analysis of the action of tranquilizing agents--benzodiazepine derivatives].
Topics: Antisocial Personality Disorder; Benzazepines; Chlordiazepoxide; Diazepam; Humans; Hypertension; Men | 1972 |
Paradoxical effects of phenothiazines.
Topics: Adult; Amitriptyline; Chlorpromazine; Diazepam; Female; Humans; Meclofenoxate; Meprobamate; Phenothi | 1968 |
Electroencephalographic analysis of atropine coma.
Topics: Atropine; Barbiturates; Bipolar Disorder; Coma; Delirium; Diazepam; Electroencephalography; Epilepsy | 1972 |
Lorazepam in the treatment of severe anxiety and anxiety associated with psychotic conditions.
Topics: Adult; Aggression; Amitriptyline; Anxiety Disorders; Ataxia; Benzodiazepinones; Bipolar Disorder; Ch | 1973 |
The care of psychotic patients.
Topics: Adult; Affective Symptoms; Ambulatory Care; Anxiety; Bipolar Disorder; Brain Damage, Chronic; Diazep | 1974 |
Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.
Topics: Animals; Antidepressive Agents; Carbon Radioisotopes; Chlordiazepoxide; Diazepam; Dose-Response Rela | 1974 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
[Drawings of a schizophrenic during a Sakel cure].
Topics: Adult; Chlorpromazine; Convulsive Therapy; Diazepam; Haloperidol; Humans; Male; Methotrimeprazine; P | 1967 |
Intravenous diazepam in drug-induced dystonic reactions.
Topics: Adult; Bipolar Disorder; Butyrophenones; Diazepam; Female; Humans; Injections, Intravenous; Male; Mi | 1972 |
[Clinical and therapeutic aspects of cyclothymic depressions of late onset].
Topics: Age Factors; Amitriptyline; Delusions; Depression; Diagnosis, Differential; Diazepam; Humans; Middle | 1971 |
[On the use of sulpiride in psychiatric therapy].
Topics: Adolescent; Adult; Aged; Amitriptyline; Butyrophenones; Diazepam; Drug Synergism; Female; Humans; Ma | 1969 |
[Parenteral treatment of depressive diseases].
Topics: Antidepressive Agents; Bipolar Disorder; Dementia; Depression; Depressive Disorder, Major; Desiprami | 1970 |
The present status of psychotropic drugs.
Topics: Antidepressive Agents; Chlormethiazole; Diazepam; Dibenzazepines; Fluphenazine; Haloperidol; Humans; | 1970 |
Treatment of psychic masochism in schizophrenic patients.
Topics: Adolescent; Adult; Amitriptyline; Behavior Therapy; Chlordiazepoxide; Diazepam; Female; Haloperidol; | 1970 |
[The basic criteria for clinical evaluation of the effect of tranquilizers].
Topics: Benactyzine; Bipolar Disorder; Central Nervous System Diseases; Chlordiazepoxide; Diazepam; Epilepsy | 1970 |
[Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions].
Topics: Animals; Anticonvulsants; Behavior, Animal; Central Nervous System Diseases; Chlordiazepoxide; Depre | 1971 |
[Management of psychotic drive disorders].
Topics: Adult; Bipolar Disorder; Chlorprothixene; Diazepam; Drive; Female; Fluphenazine; Humans; Imipramine; | 1968 |
[Use of diazepam in psychiatric practice].
Topics: Adult; Aged; Antisocial Personality Disorder; Chlordiazepoxide; Diazepam; Female; Humans; Male; Ment | 1968 |
[Medazepam. A new tranquilizer: simple test, intraindividual comparisons and combination therapy].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzazepines; Chlordiazepoxide; Depression; Diazepam | 1968 |
"Valium" in the treatment of schizophrenia.
Topics: Auditory Perception; Diazepam; Hallucinations; Humans; Schizophrenia | 1969 |
[Management of chronic schizophrenias using Valium].
Topics: Aged; Catatonia; Chronic Disease; Diazepam; Drug Synergism; Female; Humans; Paranoid Disorders; Schi | 1969 |
Extrinsic factors influencing responses to psychotherapeutic drugs.
Topics: Adult; Amitriptyline; Analysis of Variance; Black or African American; Chlorpromazine; Depression; D | 1969 |
[Valium--a hypno-tranquilizer].
Topics: Diazepam; Humans; Schizophrenia | 1966 |